Mallinckrodt Pharmaceuticals
Mallinckrodt is focused on providing innovative treatment platforms that harness the power of each individual patient’s immune system to fight disease. Our therapeutic platforms, including the latest generation THERAKOS® CELLEX® Photopheresis System, are the world’s only approved, fully-integrated systems for administering extracorporeal photopheresis. For more information about the CELLEX® System, please visit; www.therakos.com